Beta Glucan and Fucoidan - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The beta-glucan and fucoidan market size is expected to grow from USD 790 million in 2025 to USD 845.77 million in 2026 and is forecast to reach USD 1.19 billion by 2031 at 7.06% CAGR over 2026-2031. This report is Segmented by Product Type (Beta Glucan, Fucoidan), Application (Food and Beverages, Pharmaceuticals, Dietary Supplements, Cosmetics and Personal Care, Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Beta Glucan And Fucoidan Market Trends and Insights

Growing immune-health supplement spending

Demand for immune-support supplements surged after the 2020-2023 pandemic, positioning beta-glucan and fucoidan as science-backed options that rival traditional vitamin C or zinc. Yeast-derived beta-glucan standardized to 70-85% purity dominates e-commerce and specialty retail because published clinical trials link consistent daily intake to reduced upper respiratory infection incidence. Fucoidan products, often combined with astaxanthin or curcumin, appeal to consumers seeking marine-sourced bioactives, yet U.S. regulatory ambiguity around structure-function claims keeps distribution skewed toward online channels. Personalized nutrition platforms that tailor formulations based on microbiome analysis rely on batch-specific certificates of analysis, prompting suppliers to upgrade analytical capabilities. Subscription models for monthly beta-glucan deliveries gain traction in urban markets, where convenience, perceived efficacy, and transparent sourcing justify premium pricing.

Expansion in Food and Beverage Sector for Clean-Label, Fortified Products

Food manufacturers are modifying product formulations to align with clean-label requirements by substituting synthetic emulsifiers and stabilizers with functional fibers like beta-glucan, which offer both textural advantages and health benefits. Oat beta-glucan, authorized by the European Food Safety Authority (EFSA) for cholesterol-reduction claims at a daily intake of 3 grams, is being added to breakfast cereals, yogurt, and plant-based milk alternatives, helping brands differentiate in competitive markets. Soluble beta-glucan from barley is increasingly used in beverage applications, where its viscosity-enhancing properties facilitate sugar reduction without affecting mouthfeel. In bakery applications, insoluble beta-glucan is utilized to enhance dietary fiber content while preserving dough extensibility, catering to consumer demand for high-fiber bread that maintains its taste and texture. Fucoidan remains underutilized in food applications due to its seaweed-derived flavor profile and limited Generally Recognized as Safe (GRAS) affirmation in the United States. Nevertheless, Japanese and Korean food companies have effectively incorporated low-molecular-weight fucoidan into functional beverages and instant soups. In Europe, the regulatory process for novel food ingredients requires pre-market authorization, creating challenges for smaller seaweed processors but ensuring that approved ingredients gain credibility with risk-averse multinational brands.

Stringent Food Safety, Labeling, and Health-Claim Regulations

EU Novel Foods rules impose multi-year approval cycles for new fucoidan sources, favoring incumbents with existing dossiers and deterring smaller entrants. EFSA’s high evidentiary bar compels suppliers to fund expensive clinical work if they seek disease-reduction claims, weeding out anecdotal submissions. In the United States, FDA oversight of structure-function claims under DSHEA places a compliance burden on marketers who must police downstream retailers’ language or risk warning letters. Gluten-free certification becomes tricky for barley-derived beta-glucan, which may contain trace gluten despite purification. Emerging traceability mandates necessitate digital supply-chain systems that many small processors cannot yet afford.

Other drivers and restraints analyzed in the detailed report include:

• Growth in Cosmetics and Personal Care
• Advancements in Extraction and Production Technologies
• Raw-Material Price Volatility

Segment Analysis

Beta glucan held 70.88% of the market share in 2025, driven by its regulatory approval, diverse sourcing, and broad applications in food, pharmaceuticals, and supplements. Yeast-derived beta glucan dominates supplements due to its immune-activating properties, while oat and barley beta glucan are preferred in cholesterol-reducing food products. Mushroom-derived beta glucan appeals to plant-based consumers, and soluble and insoluble fractions are used in beverages, dairy, and high-fiber snacks for their functional benefits.

Fucoidan is expected to grow at an 7.78% CAGR from 2026 to 2031, supported by its anti-inflammatory and anti-coagulant properties. Derived from brown seaweed, it offers application-specific grades for cosmetics, pharmaceuticals, and functional foods. Low-molecular-weight fucoidan is gaining traction in supplements, while high-molecular-weight forms are used in wound care and drug delivery. Regulatory challenges and high production costs limit its adoption in price-sensitive markets.

Complete Report Scope:

• Product Type
  • Beta Glucan
    • Soluble
    • Insoluble
  • Fucoidan
• Application
  • Food and Beverages
  • Pharmaceuticals
  • Dietary Supplements
  • Cosmetics and Personal Care
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Middle East and Africa

Geography Analysis

Europe held 34.35% of the market share in 2025, driven by a robust oat-processing infrastructure in Scandinavia, strict Novel Foods regulations that benefit incumbents with pre-market authorization, and EFSA-approved health claims that allow premium pricing for beta-glucan-fortified products. Finland and Sweden are home to major oat mills supplying food-grade beta-glucan to breakfast cereal manufacturers and bakery ingredient distributors across the European Union. Germany and the United Kingdom are key markets for dietary supplements, where consumer awareness of beta-glucan's cholesterol-management benefits sustains consistent demand for encapsulated yeast-derived formulations. France and Italy are experiencing increased interest in clean-label bakery products featuring beta-glucan as a natural fiber source, though regulatory compliance costs and labeling challenges limit smaller regional brands. The Netherlands acts as a logistics hub for seaweed-derived fucoidan imports from Asia, with Dutch cosmetic companies leading in marine-active formulations utilizing fucoidan's anti-aging properties.

The Asia-Pacific region is expected to grow at a CAGR of 9.96% from 2026 to 2031, driven by China's expansion of yeast-fermentation capacity, Japan's advancements in fucoidan research, and Australia's focus on sustainable seaweed aquaculture. China's dietary supplement market is growing rapidly, supported by rising disposable incomes and greater health awareness among urban consumers, with yeast beta glucan positioned as a premium immune-support ingredient. Japan's pharmaceutical and cosmetic industries have been at the forefront of fucoidan applications, leveraging extensive research into brown seaweed bioactives and strong consumer acceptance of marine-sourced ingredients. South Korea's beauty brands are incorporating low-molecular-weight fucoidan into sheet masks and essence formulations, capitalizing on the K-beauty trend and consumer willingness to pay premium prices for scientifically validated actives. Australia's seaweed aquaculture sector is attracting investments from ingredient suppliers seeking sustainable fucoidan sources that align with environmental, social, and governance (ESG) criteria demanded by European and North American buyers. India's growing supplement market presents opportunities for cost-effective beta glucan formulations, though regulatory uncertainty around health claims and limited consumer awareness hinder short-term growth.

North America shows consistent demand for oat and barley beta glucan in breakfast cereals, functional beverages, and bakery products, with the United States accounting for the majority of regional consumption. Canada's natural health product regulations permit structure-function claims for beta glucan supplements, creating a supportive environment for dietary supplement brands. In Mexico, a growing middle class and rising health awareness are driving demand for fortified foods and immune-support supplements, though price sensitivity favors lower-cost beta glucan sources over premium fucoidan formulations. South America and the Middle East remain emerging markets, with Brazil and Argentina showing localized interest in immune-support supplements. Meanwhile, Saudi Arabia and the United Arab Emirates are importing halal-certified beta glucan ingredients for regional food manufacturers.

List of Companies Covered in this Report:

• Lantmännen
• Kerry Group plc
• DSM-firmenich
• Merck KGaA (Sigma-Aldrich)
• Kemin Industries
• Tate and Lyle PLC
• Marinova Pty Ltd
• Lesaffre Human Care
• Super Beta Glucan Inc.
• BASF SE
• Yaizu Suisankagaku Industry
• Caepro Inc.
• ArcticZymes Technologies ASA
• Kamerycah Co. Ltd
• Lallemand Inc.
• Angel Yeast Co. Ltd
• Ceapro Inc.
• Biothera Pharmaceuticals
• Givaudan SA (Wellmune)
• Garuda International

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support